Evolus

Evolus EOLS Stock

$7.07   5.680120%
Add to favorites
Market Cap
$467.95M
LOW - HIGH [24H]
$6.63 - $7.09
VOLUME [24H]
$802.52K
P/E Ratio
0
Earnings per share
-$0.48
ISIN
US30052C1071
Price   Prediction

Evolus Price Chart

Sorry, that's all we've gotfor now...

Evolus (EOLS) stock price today is 7.07 USD on Tech Market Middle (+5.68% on the day). Updated .

Evolus EOLS Financial and Trading Overview

Evolus stock price 7.07 USD
Previous Close 6.69 USD
Open 6.68 USD
Bid 4.47 USD x 200
Ask 7.82 USD x 200
Day's Range 6.63 - 7.02 USD
52 Week Range 3.86 - 9.31 USD
Volume 93.78K USD
Avg. Volume 921.43K USD
Market Cap 461.33M USD
Beta (5Y Monthly) 1.342
PE Ratio (TTM) N/A
EPS (TTM) -0.48 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 15.4 USD

EOLS Valuation Measures

Enterprise Value 566.69M USD
Trailing P/E N/A
Forward P/E 24.243479
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.417423
Price/Book (mrq) N/A
Enterprise Value/Revenue 1.741
Enterprise Value/EBITDA -68.482

Trading Information

Evolus Stock Price History

Beta (5Y Monthly) 1.342
52-Week Change -1.32%
S&P500 52-Week Change 10.51%
52 Week High 9.31 USD
52 Week Low 3.86 USD
50-Day Moving Average 7.52 USD
200-Day Moving Average 6.39 USD

EOLS Share Statistics

Avg. Volume (3 month) 921.43K USD
Avg. Daily Volume (10-Days) 1.53M USD
Shares Outstanding 66.19M
Float 47.66M
Short Ratio 7.75
% Held by Insiders 11.22%
% Held by Institutions 76.23%
Shares Short 6.02M
Short % of Float 9.21%
Short % of Shares Outstanding 9.10%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -9.55%
Operating Margin (ttm) -5.40%
Gross Margin 66.05%
EBITDA Margin -2.54%

Management Effectiveness

Return on Assets (ttm) -4.37%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 325.47M USD
Revenue Per Share (ttm) 4.97 USD
Quarterly Revenue Growth (yoy) 13.00%
Gross Profit (ttm) 215M USD
EBITDA -8275000 USD
Net Income Avi to Common (ttm) -31112000 USD
Diluted EPS (ttm) -0.48
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 41.7M USD
Total Cash Per Share (mrq) 0.63 USD
Total Debt (mrq) 165.58M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.417
Book Value Per Share (mrq) -0.572

Cash Flow Statement

Operating Cash Flow (ttm) -2645000 USD
Levered Free Cash Flow (ttm) 13.41M USD

Profile of Evolus

Country United States
State CA
City Newport Beach
Address 520 Newport Center Drive
ZIP 92660
Phone 949 284 4555
Website https://www.evolus.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 365

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Q&A For Evolus Stock

What is a current EOLS stock price?

Evolus EOLS stock price today per share is 7.07 USD.

How to purchase Evolus stock?

You can buy EOLS shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Evolus?

The stock symbol or ticker of Evolus is EOLS.

Which industry does the Evolus company belong to?

The Evolus industry is Drug Manufacturers - Specialty & Generic.

How many shares does Evolus have in circulation?

The max supply of Evolus shares is 66.19M.

What is Evolus Price to Earnings Ratio (PE Ratio)?

Evolus PE Ratio is now.

What was Evolus earnings per share over the trailing 12 months (TTM)?

Evolus EPS is -0.48 USD over the trailing 12 months.

Which sector does the Evolus company belong to?

The Evolus sector is Healthcare.

Evolus EOLS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
7.16B USD — 24225.3 USD — 24538.78 USD — — 7.16B USD —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Global Market Composite NQGM US 1839.01 USD —
+0.18
— — 1830.2 USD — 1855.92 USD — — — —
us US Tech Biotechnology NBI US 6971.7 USD —
-0.66
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
$2.17T
Total marketcap
$71.26B
Total volume
BTC 58.00%   •   ETH 9.96%
Dominance
Select currency